Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Actinogen Medical Limitedannounces that a recent trial designed to confirm therapeutic blood levels of the intended commercial tablet formulation of Xanamem given both with and without food demonstrated the expected blood levels
Pharmaceutical manufacturing demands consistency high precision and continuous improvement to ensure the safety and quality of medicines The new platform automates the development of digital twins
ACROBiosystems a global biotechnology company dedicated to accelerating the drug development process through innovative tools and solutions announced that it has entered into a strategic Memorandum of Understanding
To meet the growing demand for temperaturesensitive pharmaceutical logistics DHL Global Forwarding continues to enhance its cold chain capabilities in Malaysia being the first forwarder to offer a cold chain facility
Immuneering Corporation a clinicalstage oncology company focused on keeping cancer patients alive today announced a clinical supply agreement with Eli Lilly and Company NYSELLY for its secondgeneration KRAS GC inhibitor
BioThera Solutions SH a commercialstage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars and global specialty generic and consumer healthcare medicines company
Nanjing Leads Biolabs Co Ltdtoday announced the first patient has been successfully dosed in the Phase trial of LBL GPRCDCD BsAb following strong Phase data This milestone endows LBL with the potential to become the first domestic Tcell engager TCE...
Novocureannounced today that Spains Ministry of Health has made Tumor Treating Fields TTFields therapy available through the Spanish National Health System SNS for the treatment of adult patients with newly diagnosed glioblastoma
AbbVieand Gilgamesh Pharmaceuticals Inctoday announced a definitive agreement under which AbbVie will acquire Gilgameshs lead investigational candidate currently in clinical development for the treatment of patients with moderatetosevere major depres...
Vaxxas Pty Ltd the biotechnology company pioneering the highdensity microarray patch HDMAP for needlefree vaccine delivery today announced that it has secured million in its latest financing round
